Cargando…

Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation

Severe tricuspid regurgitation remains a challenging heart-valve disease to effectively treat with high morbidity and mortality at mid-term. Currently guideline-directed medical treatment is limited to escalating dose of diuretics, and the rationale and timing of open-heart surgery remains controver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdul-Jawad Altisent, Omar, Benetis, Rimantas, Rumbinaite, Egle, Mizarien, Vaida, Codina, Pau, Gual-Capllonch, Francisco, Spitaleri, Giosafat, Fernandez-Nofrerias, Eduard, Bayes-Genis, Antoni, Puri, Rishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509289/ https://www.ncbi.nlm.nih.gov/pubmed/34640619 http://dx.doi.org/10.3390/jcm10194601

Ejemplares similares

Atrial Mitral and Tricuspid Regurgitation: Sex Matters. A Call for Action to Unravel the Differences Between Women and Men
por: Gual-Capllonch, Francisco, et al.
Publicado: (2022)

Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Heterotopic caval valve implantation in severe tricuspid regurgitation
por: Sharma, Neeraj Kumar, et al.
Publicado: (2021)

Contrast-Sparing Intravascular Ultrasound–Guided Caval Valve Implantation for Severe Symptomatic Tricuspid Regurgitation
por: Denby, Kara, et al.
Publicado: (2023)

Gender-Related Differences in Heart Failure Biomarkers
por: Cediel, Germán, et al.
Publicado: (2021)

Heterotopic caval valve implantation for the management of severe tricuspid regurgitation: a case series
por: Sharkey, Aidan, et al.
Publicado: (2020)

Transcatheter Caval Valve Implantation for Tricuspid Regurgitation After Single Leaflet Device Attachment
por: Rroku, Andi, et al.
Publicado: (2022)

Renal and hepatic function of patients with severe tricuspid regurgitation undergoing inferior caval valve implantation
por: Hewing, Bernd, et al.
Publicado: (2021)

Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging
por: Werner, Paul, et al.
Publicado: (2019)

Long-term outcomes and predictors of recurrent aortic regurgitation after aortic valve-sparing and reconstructive cusp surgery: a single centre experience
por: Karciauskas, Dainius, et al.
Publicado: (2019)

Early Hemodynamics after Aortic Valve Replacement
por: Aitaliyev, Serik, et al.
Publicado: (2020)

Early outcomes of patient-prosthesis mismatch following aortic valve replacement
por: Aitaliyev, Serik, et al.
Publicado: (2021)

The First Application of Transcatheter Caval Valve Implantation for Severe Tricuspid Regurgitation in a Patient With High Surgical Risk
por: Byeon, Jaeho, et al.
Publicado: (2022)

Detection of Functionally Significant Coronary Artery Disease: Role of Regional Post Systolic Shortening
por: Rumbinaite, Egle, et al.
Publicado: (2020)

The Background of Calculating CAVI: Lesson from the Discrepancy Between CAVI and CAVI(0)
por: Takahashi, Koji, et al.
Publicado: (2020)

Safety and performance of the Vienna self-expandable transcatheter aortic valve system: 6-month results of the VIVA first-in-human feasibility study
por: Briedis, Kasparas, et al.
Publicado: (2023)

Pirfenidone as a novel cardiac protective treatment
por: Aimo, Alberto, et al.
Publicado: (2021)

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
por: Lupón, Josep, et al.
Publicado: (2021)

Feasibility of Transcatheter Caval Valve Implantation to Improve Sleep-Disordered Breathing in Patients With Severe Tricuspid Regurgitation—A Pilot Study
por: Wang, Youmeng, et al.
Publicado: (2021)

Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era
por: Altisent, Omar Abdul-Jawad, et al.
Publicado: (2020)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
por: Bayes-Genis, Antoni, et al.
Publicado: (2021)

Management of tricuspid regurgitation
por: De Bonis, Michele, et al.
Publicado: (2014)

Potential Prognostic Relevance of Left-Ventricular Global Longitudinal Strain and of the Summation of the Mitral and Tricuspid Regurgitation Volume in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2023)

Evaluation of systemic impact of tricuspid regurgitation: an appeal for the notion of tricuspid regurgitation syndrome
por: Lu, Fanglin, et al.
Publicado: (2023)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
por: Codina, Pau, et al.
Publicado: (2022)

Cardio-Ankle Vascular Index and Aging: Differences between CAVI and CAVI0
por: Giani, Anna, et al.
Publicado: (2023)

Value of myocardial deformation parameters for detecting significant coronary artery disease
por: Rumbinaite, Egle, et al.
Publicado: (2022)

Surgical management of tricuspid regurgitation: a new algorithm to minimise recurrent tricuspid regurgitation
por: Rodriguez Torres, Diego, et al.
Publicado: (2022)

Coefficients in the CAVI Equation and the Comparison Between CAVI With and Without the Coefficients Using Clinical Data
por: Takahashi, Koji, et al.
Publicado: (2019)

The Conundrum of Tricuspid Regurgitation Grading
por: Go, Yun Yun, et al.
Publicado: (2018)

Jugular Reflux and Tricuspid Regurgitation
por: Gibson, George A.
Publicado: (1880)

Comparison of Cardio-Ankle Vascular Index (CAVI) and CAVI(0) in Large Healthy and Hypertensive Populations
por: Shirai, Kohji, et al.
Publicado: (2019)

Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore
por: Florescu, Diana R., et al.
Publicado: (2022)

Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
por: Spitaleri, Giosafat, et al.
Publicado: (2022)

Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation
por: Truong, Vien T., et al.
Publicado: (2021)

Tricuspid Edge-to-Edge Repair Versus Tricuspid Valve Replacement for Severe Tricuspid Regurgitation
por: Kim, Jihoon, et al.
Publicado: (2023)

Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI(0)) in Clinical Practice
por: Alizargar, Javad, et al.
Publicado: (2020)

Recent advances in managing tricuspid regurgitation
por: Del Forno, Benedetto, et al.
Publicado: (2018)

Reoperation for isolated rheumatic tricuspid regurgitation
por: Moutakiallah, Younes, et al.
Publicado: (2018)

Diagnosis of lead-induced tricuspid regurgitation
por: Wardell, Stephan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_paafnvceu6j9gs600uk0f44369